Skip to main content

Vol. 2026 · Bill Detail · Special Edition

CivicRadar.

Wednesday, September 2, 2026

Free · Stays on your device

MI · HB6132INTRO · 12 COSPONSORS

Consumer protection: unfair trade practices; insulin drug pricing report; require by the department of attorney general. Amends 1976 PA 331 (MCL 445.901 - 445.922) by adding sec. 9b.

Where it is in the process
Plain-English Summary

This bill would require the Michigan Attorney General to investigate the pricing of prescription insulin drugs available in the state. The Attorney General would gather information from manufacturers, sellers, and other relevant parties, and then issue a public report by October 1, 2027, detailing findings and recommending policy changes to prevent overpricing. This aims to ensure consumer protections in the pricing of insulin for Michigan residents.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text

Votes
Sponsorship · 13 Sponsors
Democrat13Republican0Independent0Other0
  • D · PrimeJennifer Conlin
  • D · CoReggie Miller
  • D · CoKara Hope
  • D · CoPhil Skaggs
  • D · CoCarrie Rheingans
  • D · CoMike McFall
  • D · CoMorgan Foreman
  • D · CoJasper Martus
  • D · CoSharon MacDonell
  • D · CoJoey Andrews
  • D · CoTonya Myers Phillips
  • D · CoJimmie Wilson
  • D · CoBetsy Coffia
Read full bill text →↓ Why am I seeing this?

Want updates?

Get notified when MI HB6132 moves stage

Pick a channel below. Every option is opt-in, and we tell you exactly what we store.

Email

Identified

We store your email address and the bill ID. We'll send a confirmation link first; alerts only start after you click it. Every email has a one-click unsubscribe.

Coming soon

  • RSS feed· Atom 1.0 + JSON Feed per bill
  • Bluesky· follow a CivicRadar bot post per status change
  • Telegram· channel or DM via bot
  • Discord· channel webhook
  • WhatsApp· via WhatsApp Business
  • SMS· via Twilio